Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-03-29 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-03-29 English
INSIDE INFORMATION ANNOUNCEMENT REGARDING THE RESULTS ESTIMATE FOR THE FIRST QUARTER OF 2020
Earnings Release Classification · 95% confidence The document is an announcement titled 'INSIDE INFORMATION ANNOUNCEMENT REGARDING THE RESULTS ESTIMATE FOR THE FIRST QUARTER OF 2020' by Pharmaron Beijing Co., Ltd. It provides a preliminary estimate of the company's net profit for Q1 2020, including growth percentages and profit ranges. It explicitly states that the results estimate has not been audited and that detailed results will be disclosed in the first quarterly report to be published later. The document is relatively short (4049 characters) and serves as a preliminary earnings estimate rather than a full financial report. It does not contain actual financial statements or detailed analysis but rather a forecast and cautionary notes. This fits the category of an Earnings Release (ER), which is the initial announcement of quarterly financial results or estimates with key highlights only. Q1 2020
2020-03-29 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019' and contains detailed financial statements including consolidated statements of profit or loss, comprehensive income, financial position, and notes to the consolidated financial statements. It includes extensive financial data, comparative figures for 2018 and 2019, and detailed accounting policies. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content matches the characteristics of an Annual Report (10-K equivalent) as it covers the full financial performance and company activity for the fiscal year. It is not a short announcement or a certification letter, nor is it a regulatory filing or a report publication announcement. Therefore, the correct classification is Annual Report (10-K). FY 2019
2020-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-03-24 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notice announcing a forthcoming board meeting to consider and approve the annual results for the year ended December 31, 2019, and to consider dividend payment. It is a short announcement (1641 characters) and does not contain any financial data or the actual annual results report. It is not the annual report itself but a notice about the board meeting where the annual results will be discussed. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than a full financial report or other specific filing type.
2020-03-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.